Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial

por Araki, Eiichi, Unno, Yuriko, Tanaka, Yuko, Sakamoto, Wataru, Miyamoto, Yuki
Publicado 2019

Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study

por Yamamoto, Fumiko, Unno, Yuriko, Okamura, Tomoo, Ikeda, Rie, Ochiai, Kaori, Hayashi, Naoyuki
Publicado 2019